CAS: 2049868-46-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK'963 REF: IN-DA01FW4OCAS: 2049868-46-2 | % | To inquire | Thu 23 Jan 25 |
 | GSK963 REF: TM-T5054CAS: 2049868-46-2 | 97.45% | 35.00 €~546.00 € | Thu 30 Jan 25 |
 | GSK'963 REF: 3D-ZGD86846CAS: 2049868-46-2 | Min. 95% | To inquire | Thu 06 Mar 25 |
Ref: IN-DA01FW4O
| 1mg | 121.00 € | ||
| 5mg | 187.00 € | ||
| 100mg | 515.00 € | ||
| 250mg | 545.00 € |
Estimated delivery in United States, on Thursday 23 Jan 2025
GSK963
CAS:2049868-46-2
GSK963 (Racemate), a structurally distinct, potent and selective inhibitor of RIP1 kinase(IC50=29 nM).
Formula:
C14H18N2O
Purity:
97.45%
Color and Shape:
Solid
Molecular weight:
230.31
Ref: TM-T5054
| 1mg | 35.00 € | ||
| 2mg | 50.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 119.00 € | ||
| 25mg | 232.00 € | ||
| 50mg | 373.00 € | ||
| 100mg | 546.00 € | ||
| 1mL*10mM (DMSO) | 86.00 € |
Estimated delivery in United States, on Thursday 30 Jan 2025
GSK'963
CAS:2049868-46-2
GSK'963 is a peptide-based activator of the nicotinic acetylcholine receptor that binds to the α4β2 …
Formula:
C14H18N2O
Purity:
Min. 95%
Molecular weight:
230.31 g/mol
Ref: 3D-ZGD86846
| 25mg | 1,259.00 € | ||
| 50mg | 1,751.00 € | ||
| 100mg | 2,802.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025
